NLO is not only recommended in the Netherlands, but also in Belgium: "Dutch IP bastion NLO has made an indelible impression on the Belgian patent market since opening its Ghent office in 2015. A forerunner in life sciences and chemistry patent prosecution in Benelux, the agency is well positioned to procure and protect rights for local innovators in the East Flanders research and industrial hub. On top of precision drafting, NLO delivers flawless strategic advice from a domestic and pan-European perspective."
"Drafting and prosecuting complex biotechnology briefs is second nature to Bart Swinkels, whose practice also encompasses contentious matters: he lately assisted Novozymes in a dispute against DSM before the District Court of The Hague. A refined understanding of the pharmaceutical sector and a holistic perspective gleaned from in-house roles sets Mari Korsten apart from the crowd. Adding further dynamism to NLO’s pharmaceutical offering is Arthur Meekel, a dab hand on supplementary protection certificates (SPCs).
“A highly skilled patent agent when it comes to physics and mathematics”, Hans Hutter regularly publishes on the subject of software-related inventions. Fellow physics whizz and managing partner Hans Bottema has deep experience across the patent lifecycle. Clients in need of profitable IP strategies in the food and nutrition sector rely on David Bot for discerning counsel that straddles the contentious/non-contentious divide. Recently switching from a management position to a fully client-focused role, the commercially on-point Maarten Ketelaars specialises in medical devices and alternative energy resources. With over 13 years as an examiner at the EPO and advanced US procedural know-how under his belt, Paul Clarkson is a valuable asset for rights holders looking to bridge the Atlantic.
The extensive research process for this guide was conducted over several months by a team of full-time analysts, and involved close to 1,500 interviews with patent specialists across the globe. Legal and attorney firms and individual practitioners qualify for inclusion in the IAM Patent 1000 upon receiving sufficient positive feedback from market sources.
The online edition is available via www.iam1000.com